Status:
COMPLETED
A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus
Lead Sponsor:
Sanofi
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Primary objective: * To determine the optimal treatment algorithm for the clinical use of insulin glargine based on the incidence of severe hypoglycaemia. Secondary objectives: * To determine for e...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Subjects with Type 2 Diabetes Mellitus,
- Subjects on antidiabetic treatment (oral and/or insulin therapy) for \> 6 months,
- Subjects who require a basal long-acting insulin for the control of hyperglycaemia,
- HbA1c values \> 7.0% and \< 12 %,
- BMI \< 40 kg/m².
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Exclusion
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
End Date :
August 1 2003
Estimated Enrollment :
7376 Patients enrolled
Trial Details
Trial ID
NCT00399724
Start Date
March 1 2002
End Date
August 1 2003
Last Update
August 31 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.